Chronic Low-back Pain Clinical Trial
— MBPROfficial title:
Feasibility Clinical Trial of Integrated Mind-Body Therapy for Chronic Low Back Pain
Verified date | May 2024 |
Source | University of California, San Francisco |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a development study with clinical outcomes. The investigators aim to develop and test an 8-week MBPR (Mindfulness-Based Pain Reduction) program, which draws on intervention work and clinical experience in the investigative team to optimize a mindfulness-based intervention for individuals with chronic pain. The overall goal of this study is to ensure that the MBPR program has been carefully refined and manualized in an in-person setting before performing clinical trials comparing MBPR to MBSR (Mindfulness-Based Stress Reduction) to test whether it improves pain outcomes. This study includes a Pain Attention Task that separates insula activation during experimental heat application between different pain attention conditions.
Status | Active, not recruiting |
Enrollment | 52 |
Est. completion date | December 1, 2024 |
Est. primary completion date | December 1, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Chronic low back pain (cLBP) defined according to the NIH Research Task Force recommendation on Research Standards for cLBP: pain at least half the days in the past 6 months, by using 2 questions and a human figure drawing illustrating the region as the space between the lower posterior margin of the rib cage and the horizontal gluteal fold. 2. Average pain in the last month at least 3 out of 10 on Numeric Rating Scale [range 0 - 10, for 0 signifying no pain and 10 signifying worst pain imaginable]. This level of pain allows comparability of the study results with the majority of cLBP studies. Pain rated less than 3 is too mild to detect improvement. 3. Men and women aged 18 years old and older. The investigators are not enrolling younger children as they are not part of the Intensive Pain Rehabilitation Therapy program. 4. Eligibility will be assessed using the following questions: "(1) How long has back pain been an ongoing problem for you? and (2) How often has low-back pain been an ongoing problem for you over the past 6 months?" A response of greater than three months to question 1, and a response of "at least half the days in the past 6 months" to question 2 would meet the cLBP eligibility criterion. 5. Ability to speak English. We do not have the capacity, given the resources available in this proposal, to translate all course material and conduct groups into another language. The investiagtors have previously enrolled Hispanic participants into other studies who were fluent in English, and expect to do this in the proposed study. 6. Owning a smart phone Exclusion Criteria: 1. Unable to provide informed consent. 2. A substance abuse, mental health, or medical condition that, in the opinion of investigators, will make it difficult for the potential participant to participate or that may need immediate changes in medical management that will affect study outcome measures. Such conditions may include cancer, liver failure, renal failure, pain conditions from inflammatory diseases (e.g. rheumatoid arthritis, ankylosing spondylitis, lupus), malignancies or abdominal aortic aneurysm, muscle weakness from radiculopathy. Radiculopathy or sciatic pain is NOT excluded as long as the condition is stable and does not lead to significant movement restrictions or <4/5 muscle weakness. Persons with significant substance abuse or mental health conditions that interfere with social functioning may be disruptive. Other medical or mental health conditions that need immediate changes in management need to be addressed before starting the study so that more reliable baseline measurements can be made. Patients who may need assessment for potentially necessary surgical interventions may not be able to complete the study. Regular opioid prescription is not an exclusion if stable over the past 3 months. 3. Spine related current or history of spine infection, spine tumor, vertebral fracture, cauda equina syndrome. Condition would increase heterogeneity of the sample. 4. Blindness, severe vision problems, deafness, severe hearing problems, bipolar or manic depression and not taking medication, major depression, psychoses (major), a substance abuse condition, dementia, unable to get up and down from the floor. Condition might make it difficult to participate. 5. Some other serious medical conditions that may alter key study outcomes, including untreated hypothyroidism, renal failure, and cirrhosis. Conditions that may alter key study outcomes. 6. Involvement in a lawsuit related to their back. Complicated medico-legal issues that could lead to individuals having a financial incentive to not report improvement. 7. Involved in Worker's Compensation claim. 8. Pregnant, breast-feeding, or planning to get pregnant in the next 12 months or less than 3 months post-partum. Particular back problems than may be associated with pregnancy and delivery may confound study outcomes. 9. Lack of stable housing or plan to move out of the area within the next 6 months. 10. MRI-related exclusion criteria: Cardiac pacemaker, metal fragments in eyes/skin/body (shrapnel), subjects who have ever been a metal worker/welder; history of eye surgery/eyes washed out because of metal, aortic aneurysm clips, prosthesis, by-pass surgery/coronary artery clips, hearing aid, heart valve replacement, subjects with an I.U.D, a shunt (ventricular or spinal), electrodes, metal plates/ pins/screws/wires, or neuro/bio-stimulators (TENS unit), vision problems uncorrectable with lenses, claustrophobia; inability to lie still on one's back for approximately 60 minutes; prior neurosurgery; older tattoos with metal dyes; unwillingness to remove nose, ear or face jewelry, braces or permanent dental retainers. Iron-containing metal parts in the body can potentially be dislocated by strong magnetic fields and preclude assessment with MRI. 11. Received a steroid or botox injection in or near the spine in the last 3 months. This may alter key study outcomes. |
Country | Name | City | State |
---|---|---|---|
United States | University of California San Francisco; Osher Center for Intgerative Medicine | San Francisco | California |
Lead Sponsor | Collaborator |
---|---|
University of California, San Francisco | National Center for Complementary and Integrative Health (NCCIH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Interoceptive Awareness | change in scores for the 8 scales of the Multidimensional Assessment of Interoceptive Awareness (MAIA-2) [6-point Likert scale Never to Always] will be assessed by internet-based questionnaire using REDCap | baseline, post 8-week intervention, 6 months follow-up | |
Other | Changes in insula cortex activation / connectivity | using fMRI | baseline, post 8-week intervention. | |
Primary | Pain Intensity | Change in average pain intensity in past week on Numeric Rating Scale [0 to 10] will be assessed by internet-based questionnaire using REDCap | baseline, post 8-week intervention, 6 months follow-up | |
Secondary | Pain Interference | Change in average of the scores for the 3 Pain Interference items on PROMIS-29 [5-point Likert scale from "Not at all" to "Very much"] average for past week will be assessed by internet-based questionnaire using REDCap | baseline, post 8-week intervention, 6 months follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05963451 -
Brain, Psychological and Epigenetic Determinants for Optimizing the Treatment of Chronic Low Back Pain
|
||
Completed |
NCT04283370 -
A Study Protocol Comparing a Home Rehabilitation Program Versus e-Health Program in Low Back Pain
|
N/A | |
Completed |
NCT04824547 -
Evaluation of Long-Term Continuity of Exercises in Low Back Pain Individuals
|
N/A | |
Completed |
NCT04046419 -
In Turkish Version "Health Care Providers and Impairment Relationship Scale (HC-PAIRS)"
|
||
Completed |
NCT04399772 -
COgNitive FuncTional Therapy+ for Chronic Low Back paIn
|
N/A | |
Recruiting |
NCT05780021 -
Motivational Support Program in Chronic Low Back Pain After Multidisciplinary Functional Rehabilitation
|
N/A | |
Completed |
NCT04555278 -
Combining Non-invasive Brain Stimulation and Exercise to Treat Low Back Pain
|
N/A | |
Completed |
NCT04530071 -
Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06080464 -
Clinician Satisfaction With the VERABAND™
|
N/A | |
Not yet recruiting |
NCT06347328 -
The Benefits of Posterior Joint Infiltration in Chronic Low Back Pain
|
N/A | |
Not yet recruiting |
NCT04940715 -
Efficacy of Passive Joint Mobilization vs Mobilization With Movement on Pain Processing in Patients With Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT04683718 -
A First in Human Feasibility Study to Evaluate the Safety and Effectiveness of the BIOTRONIK Prospera SCS System With HomeStream Remote Management
|
N/A | |
Recruiting |
NCT05724160 -
Using Non-Weightbearing Stationary Elliptical Machines for Patients With Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT06030128 -
Core Stabilization Exercise Therapy in Chronic Lower Back Back Management in Community Dwelling Older Adults
|
N/A | |
Recruiting |
NCT05846087 -
Mobile App-delivered Sleep Therapy (SleepFix) for Individuals With Chronic Low Back Pain and Insomnia
|
N/A | |
Active, not recruiting |
NCT05396014 -
The BEST Trial: Biomarkers for Evaluating Spine Treatments
|
Phase 4 | |
Active, not recruiting |
NCT06140862 -
Ankle Spine Syndrome "RAFFET Syndrome II
|
N/A | |
Completed |
NCT05512338 -
Motivation and Adherence to Exercise Recommendations
|
N/A | |
Recruiting |
NCT05021146 -
Essential Oil for Chronic Low Back Pain
|
N/A | |
Completed |
NCT05690178 -
Deep Tissue Massage in Office Workers With Chronic Low Back Pain
|
N/A |